Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03695913
Other study ID # HUM00145667
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 16, 2018
Est. completion date September 26, 2019

Study information

Verified date February 2020
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will recruit pre-diabetic patients to see if continuous glucose monitoring (CGM) with a low carbohydrate diet can reduce the percentage of time the CGM readings are above the normal range. Through this study it will demonstrate the feasibility of using CGM with a low carbohydrate diet to reduce weight and risk of developing diabetes in patients with pre-diabetes.

Patients that appear to be eligible will be recruited from Michigan Medicine in the Family Medicine Clinic at the Livonia Center.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date September 26, 2019
Est. primary completion date March 7, 2019
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria:

- A1C Glucose Measurement between 5.7 to 6.4 (for most recent A1C test, not older than 1 year)

- No diabetes medication including Metformin

- BMI (body mass index) >30

- Must speak, read, and write in English

- No current pregnancy or breastfeeding

- Must not classify as either Vegan or Vegetarian

- Must be a patient at the Livonia Health Center

Exclusion Criteria:

- previous bariatric surgery

Study Design


Intervention

Other:
Normal Diet
Phase I (regular diet): all participants will eat their normal diet and will log their food.
Low carb diet
Phase II (low carb diet): participants will be asked to eat a low carb diet and log their food
Device:
CGM with no real time feedback
Phase I will collect CGM without real time feedback
CGM with real time feedback)
Phase II participants will be asked to scan their sensor at least every eight hours and document their blood sugar before and two hours after eating as well as before breakfast and before going to bed.
Behavioral:
Education material
Phase I: participants will be given the book Always Hungry and be asked to read chapters 1-5 after a health check phone call approximately 5 days after the sensor is placed. Phase II: participants will be taught about carbohydrates and the benefits and side effects. Additionally, they will be given multiple resources to assist them regarding carbohydrates as well as a book entitled "The Calorie King, Calories, Fat, and Carbohydrates." Groceries will also be delivered for 2 recipes that the participants choose from to make.

Locations

Country Name City State
United States The University of Michigan Livonia Michigan

Sponsors (1)

Lead Sponsor Collaborator
University of Michigan

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Participant Satisfaction With Continuous Glucose Monitoring (CGM) Satisfaction is measured using responses to the post intervention survey question, "How likely are you to recommend that a friend or family member with pre-diabetes wear a continuous glucose monitor (CGM)?". A 5 point scale was used, ranging from 1 to 5, where a score of 1 is "extremely likely" and 5 is "would not recommend". Satisfied respondents answered either 1 or 2 on the scale. 33 days after day 1 (visit 3 completion)
Primary Participant Satisfaction With Continuous Glucose Monitoring Common qualitative themes related to participant satisfaction with CGM from post intervention interview were coded. 60 days (30 days after visit 3 completion)
Secondary Feasibility, Measured by Recruitment Successful recruitment completed within 3 months 3 months
Secondary Feasibility of Pre-diabetic Patients to Wear CGM Sensors Feasibility is measured by the number of participants who wore a sensor for at least 20 out of 22 days completed within 60 days of enrollment
Secondary Weight Change Change between visit 1 and the final visit. day 11 (visit 2), day 22 (visit 3)
Secondary Change in Percentage of Time Glucose is Above 140 Comparison between the first sensor wear period and the second sensor wear period. 33 days after day 1
Secondary Number of Participants Who Reported Side Effects of Low Carbohydrate Eating and CGM at Health Check Phone Call During the health check phone call survey, participants were asked to report whether they experienced any side effects. Approximately 5 days each new sensor is placed (days 5 and 16)
Secondary Number of Participants Who Reported Side Effects of Low Carbohydrate Eating and CGM in Patient Log In the patient side effect log, participants recorded whether they experienced any side effects. days 11 through 22
Secondary Change in Knowledge of Low Carbohydrate Eating The Low Carbohydrate Knowledge Scale ranges from 15-41, where 15 is a low score and 41 is a high score. Participants were asked to report knowledge at baseline and completion. A positive score indicates an increase from baseline in knowledge, while a score of 15 indicates no change and a negative score indicates a decrease in knowledge from baseline. baseline, day 22
Secondary Change in Cravings From Day 11 to Day 22 Participants recorded cravings in food logs. Craving rating scale ranges from 1 to 5, where a score of 1 is low and a score of 5 is high. 11 days
Secondary Intention to Continue Low Carbohydrate Eating The completion survey asked participants a question, "How confident are you that you can maintain a low carbohydrate diet for the next 12 months?" Intention to Continue Low Carbohydrate eating used a scale of 1 to 5, where a score of 1 was not confident at all and a score of 5 was very confident. day 22
Secondary Utility of CGM Feedback for Changing Diet Utility of CGM feedback is expressed as the number of participants who qualitatively indicated that CGM feedback helped them to change their diet. Themes were identified and coded from qualitative interviews around this topic. Two qualitative coders identified themes that supported this construct. 60 days (30 days after visit 3 completion)
See also
  Status Clinical Trial Phase
Completed NCT04082585 - Total Health Improvement Program Research Project
Enrolling by invitation NCT05367024 - Broccoli Effect on Glycated Haemoglobin (HbA1c) N/A
Completed NCT02933424 - Project Plant Protein: the P3 Study in Humans N/A
Withdrawn NCT02400450 - Designer Functional Foods on Parameters of Metabolic and Vascular in Prediabetes N/A
Completed NCT02656212 - Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2) Phase 1
Completed NCT02330276 - Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin Phase 1
Completed NCT01488279 - Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy N/A
Completed NCT00831129 - A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs Phase 2/Phase 3
Completed NCT00536250 - Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth N/A
Recruiting NCT05563090 - Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
Active, not recruiting NCT04991142 - Models of Nutrition From Continuous Glucose Monitors
Completed NCT02759055 - Pre-Diabetes Cardiovascular (CV) Care (Pre-Diabetes Wizard) N/A
Completed NCT00775684 - Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass N/A
Completed NCT04051008 - CTSI Pilot: Improving Adherence to Diabetic Diet N/A
Recruiting NCT04897945 - A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus N/A
Not yet recruiting NCT04442451 - Mechanisms of Fatigability With Diabetes N/A
Not yet recruiting NCT05925933 - High Protein Diet on Transcriptomic, Metabolomics, Hepatic and Pancreatic Fat Anatomy and Physiology in Asian Indians With Pre-diabetes N/A
Active, not recruiting NCT05654051 - The SLIM LIVER Study Phase 2
Completed NCT02919397 - Motivational Instant Messaging and E-diabetes Prevention Programme for High Risk of Type 2 Diabetes N/A
Completed NCT00589459 - Gender Differences in Prevalence of Undiagnosed Diabetes in ACS